Insider Shareholders with Direct Ownership of Leap Therapeutics, Inc. (LPTX)
This section provides a comprehensive overview of the insiders with direct ownership of Leap Therapeutics, Inc. (LPTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LEAP THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bei Gene, Ltd.
> 10% Shareholder |
2,543,800 | 0 | 7,348,437 $2.87 Million | 1 |
Sep 24, 2021
Added 25.72%
|
|
Douglas E Onsi
CEO,CFO,Pres.,GC,Treas.&Sec. |
700,606 | 0 | 106,146 $41,396 | 3 |
Mar 28, 2025
Added 23.44%
|
|
Cynthia Sirard
Chief Medical Officer |
27,500 | 0 | 27,500 $10,725 | 2 |
Mar 28, 2025
Added 45.0%
|
|
John Mark O'Mahony
Chief Manufacturing Officer |
27,500 | 0 | 27,500 $10,725 | 2 |
Mar 28, 2025
Added 45.0%
|
|
Christopher Mirabelli
Chairman of the Board |
27,500 | 6,672 | 20,914 $8,156 | 3 |
Mar 28, 2025
Reduced 24.19%
|
|
Augustine Lawlor
Chief Operating Officer |
27,500 | 7,797 | 19,789 $7,717 | 3 |
Mar 28, 2025
Reduced 28.26%
|
|
Christine Granfield
VP, Head of Reg Affairs/Qual |
22,500 | 6,604 | 15,896 $6,199 | 2 |
Mar 28, 2025
Reduced 29.35%
|
|
Jason Baum
Chief Scientific Officer |
22,500 | 6,604 | 15,896 $6,199 | 2 |
Mar 28, 2025
Reduced 29.35%
|
|
James H Cavanaugh
Director |
213 | 0 | 213 $83 | 1 |
Nov 13, 2024
Added 50.0%
|
|
Health Care Ventures Viii, L.P.
> 10% Shareholder |
0 | 2,618,406 | 0 $0 | 1 |
Dec 28, 2020
Reduced 100.0%
|